MBX Biosciences, Inc. Common Stock
USD60.28
+0.14 (+0.23%)
CEO
Peter Kent Hawryluk
IPO Date
2024-09-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$60.27
Prev. Close
$60.14
Day Low
$58.37
Day High
$61.17
52W Low
$9.63
52W High
$66.55
Market Cap
$2.02B
Volume
0.69M
| 12,500 |
| $30.91 |
| 5 Jun 2026 | Heron Patrick J | director, 10 percent owner: | A-Award | Acquired | 12,500 | $30.91 |
| 5 Jun 2026 | Stelzer Laurie | director | A-Award | Acquired | 12,500 | $30.91 |
| 5 Jun 2026 | Hoerter Steven L. | director | A-Award | Acquired | 12,500 | $30.91 |
| 5 Jun 2026 | Ryder Steven | director | A-Award | Acquired | 12,500 | $30.91 |
| 5 Jun 2026 | Aynechi Tiba | director | A-Award | Acquired | 12,500 | $30.91 |
| 11 May 2026 | Azoulay Salomon | Chief Medical Officer | M-Exempt | Acquired | 55,000 | $10.46 |
| 11 May 2026 | Azoulay Salomon | Chief Medical Officer | S-Sale | Disposed | 55,000 | $38.38 |
| 11 May 2026 | Azoulay Salomon | Chief Medical Officer | M-Exempt | Acquired | 15,003 | $16.00 |